[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,158 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-07-08 | Class II | Medline Industries, LPZ-2609-2026 | Kits contain Swan-Ganz catheters recalled by Becton Dickinson (BD). BD has received complaints of leaks/breakage involving failures of the (blue) proximal injectate lumen hub on these catheters. This has led to instances of leakage, lumen damage, and breakage, and may lead to infection, medication loss, and/or blood loss. | Risk Management & CAPA |
| 2026-07-08 | Class II | Bard Access Systems, Inc.Z-2656-2026 | Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier. | Risk Management & CAPA |
| 2026-07-08 | Class II | Siemens Medical Solutions USA, IncZ-2643-2026 | Potential for loss of movement capability after adjusting the detector lift height to its maximum or minimum limits. | — |
| 2026-07-08 | Class II | Accuray IncorporatedZ-2640-2026 | In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room control pendant, the collimator may release and fall from the housing. | — |
| 2026-07-08 | Class II | Boston Scientific CorporationZ-2630-2026 | Potential sterile breach of the pouches in which devices are packaged. | Environmental Monitoring |
| 2026-07-08 | Class II | Medline Industries, LPZ-2541-2026 | The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent FDA manufacturing inspection of its drug manufacturing site. | Risk Management & CAPA |
| 2026-07-08 | Class II | Bard Access Systems, Inc.Z-2664-2026 | Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier. | Risk Management & CAPA |
| 2026-07-08 | Class II | Bard Access Systems, Inc.Z-2657-2026 | Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier. | Risk Management & CAPA |
| 2026-07-08 | Class II | Medline Industries, LPZ-2612-2026 | Kits contain Swan-Ganz catheters recalled by Becton Dickinson (BD). BD has received complaints of leaks/breakage involving failures of the (blue) proximal injectate lumen hub on these catheters. This has led to instances of leakage, lumen damage, and breakage, and may lead to infection, medication loss, and/or blood loss. | Risk Management & CAPA |
| 2026-07-08 | Class II | Bard Access Systems, Inc.Z-2658-2026 | Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier. | Risk Management & CAPA |
| 2026-07-08 | Class II | Medline Industries, LPZ-2544-2026 | The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent FDA manufacturing inspection of its drug manufacturing site. | Risk Management & CAPA |
| 2026-07-08 | Class II | Remel, IncZ-2623-2026 | Reduced or no recovery of some strains of Neisseria gonorrhoeae. | — |
| 2026-07-08 | Class II | RAYSEARCH LABORATORIES ABZ-2647-2026 | Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change. | — |
| 2026-07-08 | Class II | Boston Scientific CorporationZ-2636-2026 | Potential sterile breach of the pouches in which devices are packaged. | Environmental Monitoring |
| 2026-07-08 | Class II | Medline Industries, LPZ-2534-2026 | The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent FDA manufacturing inspection of its drug manufacturing site. | Risk Management & CAPA |
| 2026-07-08 | Class II | RAYSEARCH LABORATORIES ABZ-2646-2026 | Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change. | — |
| 2026-07-08 | Class II | Mentor Texas LPZ-2614-2026 | A single lot of expired syringes were distributed due to a distribution system control failure. | Validation & Qualification |
| 2026-07-08 | Class II | TELEFLEX LLCZ-2639-2026 | Due to out-of-specification, or potential out-of-specification, levels of endotoxins | Environmental Monitoring |
| 2026-07-08 | Class II | Medline Industries, LPZ-2535-2026 | The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent FDA manufacturing inspection of its drug manufacturing site. | Risk Management & CAPA |
| 2026-07-08 | Class I | Windstone Medical Packaging, Inc.Z-2622-2026 | Kits contain Webcol Large Alcohol Prep Pad which were recalled by Cardinal Health following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit. | Environmental Monitoring |
| 2026-07-08 | Class II | Zimmer Surgical IncZ-2674-2026 | Potential sterility breach in sealing area of sterile pouch. If used, issue may result in moderate localized infection. If discovered prior to use, may result in clinically insignificant extension of surgery to find another readily available device. | Environmental Monitoring |
| 2026-07-08 | Class II | Carl Zeiss Meditec AGZ-2649-2026 | Spherical applicators (radiation therapy accessory) failed to meet manufacturing specifications. | Risk Management & CAPA |
| 2026-07-08 | Class II | DEPUY (IRELAND)Z-2617-2026 | The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility. | Environmental Monitoring |
| 2026-07-08 | Class II | Medline Industries, LPZ-2539-2026 | The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent FDA manufacturing inspection of its drug manufacturing site. | Risk Management & CAPA |
| 2026-07-08 | Class II | Bard Access Systems, Inc.Z-2668-2026 | Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier. | Risk Management & CAPA |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.